Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FE0FY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 12, 2025, for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with a completion deadline of October 3, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace based on its capabilities and pricing.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valued through November 2026 that authorizes firm fixed-price orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Stelara, a biologic immunosuppressant medication, is among the extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies through this blanket contract. The vendor's established role as a critical supplier in the federal pharmaceutical supply chain demonstrates DMS's reliability in delivering specialized pharmaceutical products to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FE0FY?
SPE2DB25FE0FY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FE0FY worth?
The government has obligated $32,500 on SPE2DB25FE0FY.
Is contract SPE2DB25FE0FY an order under another contract?
Yes. SPE2DB25FE0FY is a delivery order under SPE2DB22D9130, an indefinite delivery contract.
Was contract SPE2DB25FE0FY competed?
The extent of competition for SPE2DB25FE0FY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award